The present invention features rifamycin analogs that can be used as
therapeutics for treating or preventing a variety of microbial
infections. In one form, the analogs are acetylated at the 25-position,
as is rifamycin. In another form, the analogs are deacetylated at the
25-position. In yet other forms, benzoxazinorifamycin,
benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized
at various positions of the benzene ring, including 3'-hydroxy analogs,
4'- and/or 6' halo and/or alkoxy analogs, and various 5' substituents
that incorporate a cyclic amine moiety.